tradingkey.logo

Onkure Therapeutics Inc <OKUR.OQ> expected to post a loss of $1.46 a share - Earnings Preview

ReutersMay 2, 2025 1:24 PM
  • Onkure Therapeutics Inc OKUR.OQ OKUR.O is expected to show no change in quarterly revenue when it reports results on May 5 (estimated) for the period ending March 31 2025

  • ​LSEG's mean analyst estimate for Onkure Therapeutics Inc is for a loss of $1.46 per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Onkure Therapeutics Inc is $32.00​, above​ its last closing price of $2.50. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Dec. 31 2024

-0.74

-1.37

Missed

-85.1

Sep. 30 2024

-1.03

-1.03

-1.10

Missed

-6.8

Jun. 30 2024

-1.00

-1.60

Missed

-60​

Mar. 31 2024

-4.63

-4.37

-2.50

Beat

42.7

​​Dec. 31 2023

-5.57

-5.78

-7.10

Missed

-22.9

Sep. 30 2023

-5.66

-5.71

-5.70

Beat

0.3​

Jun. 30 2023

-5.02

-5.17

-6.50

Missed

-25.8

Mar. 31 2023

-5.93

-6.04

-6.00

Beat

0.7

This summary was machine generated May 2 at 13:24 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI